CytoSwim ltd. is a spin-out from the University of Warwick and was founded in 2019.
Our mission is to provide new and effective tools and systems for the selection of the highest quality sperm cells with the least damage compared to other methods, thereby enabling IVF clinics to confidently select the very best sperm cells and thereby ensure the highest chance of success for their patients. We aim to do this by commercialising the microstructured sperm separation technology developed by founders Dr. Max Meissner and Dr. Vasily Kantsler, which allows for highly effective sperm separation without needing to apply any external fields. This technology is protected by a patent which is exclusively licensed to the company.
CytoSwim ltd. has secured seed investment from Oxford Technology Management and obtained grant funding from InnovateUK and Micra to develop its first generation of sperm conditioning chips.
The next opportunity to invest in CytoSwim ltd. will be in Summer 2021.